top of page

The Foot & Ankle Consolidation Trend Continues

On May 4, CONMED Corporation (NYSE: CNMD) announced a definitive agreement to acquire privately-held In2Bones Global, Inc. for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period.

In2Bone, led by foot and ankle veteran Alan Taylor, had 2021 revenue of $36.8 million with sustained double-digit growth. While CONMED is a large company, including 3,500 employees, it has a small footprint in foot and ankle, making this a partnership an upside on both sides.

10 views0 comments

Recent Posts

See All

Joint Line Considerations in TAA

by Vince Vacketta, DPM The importance of restoring the native joint line has been well studied in TKA. As surgeons continue to work to improve total ankle arthroplasty (TAA) results, new research focu

Comments


FIX Masthead 2000x318 v2.jpg
bottom of page